Skip to content
Contact
About PORTAL
Our Team
Our Work
Innovation Incentives and Competition
Regulation and Clinical Evidence
Price, Value, and Access
Search Our Library
Testimony: The Public Health Risks of Expanding Off-Label Promotion of Prescription Drugs and Devices
HOME
/
Policy Interactions
/
Testimony: The Public Health Risks of Expanding Off-Label Promotion of Prescription Drugs and Devices